Market Overview

Cowen Initiates Synta Pharmaceuticals At Outperform

Related SNTA
Mid-Afternoon Market Update: 3D Systems Shares Climb On Bank Of America Upgrade; Energy XXI Shares Tumble
Mid-Day Market Update: Seagate Drops Following Q3 Guidance; Sunedison Shares Surge

Cowen initiated coverage on Synta Pharmaceuticals Corp (NASDAQ: SNTA) with a Outperform rating.

Latest Ratings for SNTA

Oct 2015Roth CapitalDowngradesBuyNeutral
Apr 2015FBR CapitalInitiates Coverage onOutperform
Apr 2015Canaccord GenuityInitiates Coverage onOutperform

View More Analyst Ratings for SNTA
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityInitiation Analyst Ratings


Related Articles (SNTA)

View Comments and Join the Discussion!